Publisher
Springer Science and Business Media LLC
Reference35 articles.
1. Nemeth Z, Kun B, Demetrovics Z. The involvement of gamma-hydroxybutyrate in reported sexual assaults: a systematic review. J Psychopharmacol 2010;24(9): 1281–7.
2. Europäische Beobachtungsstelle für Drogen und Drogensucht (EMCDDA). Europäischer Drogenbericht 2016. Verfügbar:
https://doi.org/www.emcdda.europa.eu/publications/edr/trends-developments/2016
(letzter Zugriff: 31.01.2017).
3. Dines AM, Wood DM, Yates C et al. Acute recreational drug and new psychoactive substance toxicity in Europe: 12 months data collection from the European Drug Emergencies Network (Euro-DEN). Clin Toxicol 2015, 53(9): 893–900.
4. Nelson T, Kaufman E, Kline J et al. The extraneural distribution of gamma-hydroxybutyrate. J Neurochem 1981; 37(5): 1345–8.
5. Corkery JM, Loi B, Claridge H et al. Gamma hydroxybutyrate (GHB), gamma butyrolactone (GBL) and 1,4-butanediol (1,4-BD; BDO): A literature review with a focus on UK fatalities related to non-medical use. Neuroscience Biobehavioral Rev 2015;53: 52–78.